ESSA Pharma (EPIX) Short Interest Ratio & Short Volume $0.20 -0.01 (-3.90%) Closing price 10/8/2025 07:49 PM EasternExtended Trading$0.20 0.00 (0.00%) As of 10/8/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ESSA Pharma Short Interest DataESSA Pharma (EPIX) has a short interest of 1.35 million shares. This marks a -63.11% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 2.99 million shares to cover all short positions.Current Short Interest1,350,000 sharesPrevious Short Interest3,660,000 sharesChange Vs. Previous Month-63.11%Dollar Volume Sold Short$259.61 thousandShort Interest Ratio0.2 Days to CoverLast Record DateSeptember 15, 2025Outstanding Shares47,308,000 sharesPercentage of Shares Shorted2.85%Today's Trading Volume5,945,100 sharesAverage Trading Volume2,994,715 sharesToday's Volume Vs. Average199% Short Selling ESSA Pharma? Sign up to receive the latest short interest report for ESSA Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartEPIX Short Interest Over TimeEPIX Days to Cover Over TimeEPIX Percentage of Float Shorted Over Time ESSA Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/15/20251,350,000 shares $259.61 thousand -63.1%N/A0.2 $0.19 8/31/20253,660,000 shares $878.40 thousand +281.6%9.2%0.6 $0.24 8/15/2025959,100 shares $1.85 million +24.5%N/A0.2 $1.93 7/31/2025770,400 shares $1.45 million +12.4%2.1%3.2 $1.88 7/15/2025685,700 shares $1.28 million -8.3%N/A3 $1.87 6/30/2025748,000 shares $1.27 million +4.0%2.0%5.3 $1.70 6/15/2025719,100 shares $1.20 million +4.8%1.9%4.8 $1.67 5/31/2025686,100 shares $1.15 million -1.3%1.8%4.4 $1.68 5/15/2025695,100 shares $1.19 million -2.1%1.9%4.3 $1.71 4/30/2025709,700 shares $1.29 million +12.3%N/A3.6 $1.82 Get the Latest News and Ratings for EPIX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ESSA Pharma and its competitors with MarketBeat's FREE daily newsletter. 4/15/2025631,800 shares $1.03 million -0.5%1.7%3.3 $1.63 3/31/2025634,900 shares $1.00 million -0.7%1.7%3.7 $1.58 3/15/2025639,100 shares $1.04 million -0.6%1.7%2.6 $1.62 2/28/2025643,100 shares $1.08 million -5.2%1.7%2.3 $1.68 2/15/2025678,200 shares $1.17 million +6.3%1.8%2.2 $1.73 1/31/2025638,200 shares $1.10 million -4.6%N/A1.7 $1.72 1/15/2025668,900 shares $1.18 million -25.8%N/A0.7 $1.76 12/31/2024901,200 shares $1.61 million -5.3%N/A0.9 $1.79 12/15/2024951,500 shares $1.56 million +37.6%N/A1.1 $1.64 11/30/2024691,500 shares $1.24 million -4.8%N/A0.8 $1.79 11/15/2024726,500 shares $1.25 million -36.8%N/A0.9 $1.72 10/31/20241,150,000 shares $5.98 million No ChangeN/A1.5 $5.20 10/15/20241,150,000 shares $6.84 million +2.7%N/A19.5 $5.95 9/30/20241,120,000 shares $6.79 million +4.7%N/A19.8 $6.06 9/15/20241,070,000 shares $7.33 million +3.9%N/A19.1 $6.85 8/31/20241,030,000 shares $5.76 million No ChangeN/A18.9 $5.59 8/15/20241,030,000 shares $4.91 million +3.0%N/A23.6 $4.77 7/31/20241,000,000 shares $5.35 million -1.0%N/A20.4 $5.35 7/15/20241,010,000 shares $5.67 million No ChangeN/A18.7 $5.61 6/30/20241,010,000 shares $5.31 million +14.4%N/A18.4 $5.26 6/15/2024883,100 shares $4.74 million +4.7%N/A14.2 $5.37 5/31/2024843,700 shares $5.69 million -7.6%N/A14.4 $6.75 5/15/2024913,100 shares $5.66 million -1.5%N/A13.9 $6.20 4/30/2024926,500 shares $5.96 million +20.4%N/A8.7 $6.43 4/15/2024769,300 shares $5.62 million -4.2%N/A5.8 $7.30 3/31/2024802,800 shares $6.82 million -13.6%N/A5.2 $8.49 3/15/2024928,600 shares $8.36 million -5.2%4.6%6.1 $9.00 2/29/2024979,400 shares $9.30 million -13.3%4.8%6.3 $9.50 2/15/20241,130,000 shares $11.25 million -19.9%5.6%7.4 $9.96 1/31/20241,410,000 shares $11.69 million +5.2%7.1%9.5 $8.29 1/15/20241,340,000 shares $13.32 million No Change6.7%7.8 $9.94 12/31/20231,340,000 shares $8.84 million -1.5%6.7%6.9 $6.60 12/15/20231,360,000 shares $8.47 million -2.9%6.8%7.1 $6.23 11/30/20231,400,000 shares $7.45 million +1.5%7.0%7.7 $5.32 11/15/20231,380,000 shares $7.25 million +1.5%6.9%7.8 $5.25 10/31/20231,360,000 shares $6.32 million +3,959.7%6.8%8.3 $4.65 10/15/202333,500 shares $91.79 thousand -32.5%0.2%0.3 $2.74 9/30/202349,600 shares $153.26 thousand +73.4%0.3%1.7 $3.09 9/15/202328,600 shares $75.79 thousand -4.7%0.1%0.9 $2.65 8/31/202330,000 shares $90 thousand -42.2%0.2%0.9 $3.00 8/15/202351,900 shares $159.85 thousand +8.1%0.3%1.4 $3.08 7/31/202348,000 shares $144.96 thousand -29.1%0.2%1.3 $3.02 7/15/202367,700 shares $192.95 thousand -27.9%0.4%1.7 $2.85 6/30/202393,900 shares $253.53 thousand -21.6%0.5%1.9 $2.70 6/15/2023119,700 shares $389.03 thousand -18.5%0.6%2.2 $3.25 5/31/2023146,900 shares $440.70 thousand -14.1%0.8%2.2 $3.00 5/15/2023171,000 shares $499.32 thousand -11.2%0.9%2.3 $2.92 4/30/2023192,600 shares $529.65 thousand -33.8%1.0%1.7 $2.75 4/15/2023290,900 shares $805.79 thousand +2.8%1.6%1.9 $2.77 3/31/2023282,900 shares $840.21 thousand -1.4%1.5%1.4 $2.97 3/15/2023287,000 shares $826.56 thousand +21.2%1.5%1.3 $2.88 2/28/2023236,800 shares $796.83 thousand +17.0%1.3%1 $3.37 2/15/2023202,400 shares $718.52 thousand -26.6%1.1%0.7 $3.55 1/31/2023275,800 shares $783.27 thousand -20.6%1.5%0.9 $2.84 1/15/2023347,500 shares $966.05 thousand -1.6%1.9%0.1 $2.78 12/30/2022353,000 shares $889.56 thousand -18.1%1.9%0.1 $2.52 12/15/2022431,100 shares $1.22 million -20.9%2.3%0.1 $2.84 11/30/2022545,000 shares $2.01 million -11.9%2.9%0.2 $3.69 11/15/2022618,300 shares $2.46 million -69.4%3.3%0.2 $3.98 10/31/20222,020,000 shares $7.27 million +472.9%11.6%0.6 $3.60 10/15/2022352,600 shares $691.10 thousand -5.7%2.0%2.1 $1.96 9/30/2022373,800 shares $680.32 thousand +5.4%2.2%1.5 $1.82 9/15/2022354,500 shares $794.08 thousand -5.5%2.0%0.9 $2.24 8/31/2022375,000 shares $967.50 thousand +28.1%2.2%1 $2.58 8/15/2022292,800 shares $878.40 thousand -8.7%1.7%0.7 $3.00 7/31/2022320,800 shares $907.86 thousand -3.2%1.9%0.8 $2.83 7/15/2022331,400 shares $1.05 million -85.2%1.9%0.8 $3.17 6/30/20222,240,000 shares $7.06 million -4.7%12.9%7.4 $3.15 6/15/20222,350,000 shares $10.55 million -7.1%13.5%10.2 $4.49 5/31/20222,530,000 shares $12.78 million +1.2%14.6%9.5 $5.05 5/15/20222,500,000 shares $14.78 million +11.6%14.4%10 $5.91 4/30/20222,240,000 shares $12.70 million +4.7%13.1%9.1 $5.67 4/15/20222,140,000 shares $16.16 million +13.2%12.5%8.7 $7.55 3/31/20221,890,000 shares $11.68 million +81.7%11.0%6.9 $6.18 3/15/20221,040,000 shares $6.56 million +43.6%6.1%4.8 $6.31 2/28/2022724,100 shares $5.92 million +9.8%4.2%4 $8.17 2/15/2022659,800 shares $6.44 million +21.8%3.9%3.2 $9.76 1/31/2022541,800 shares $5.04 million -17.7%3.2%2.1 $9.31 1/15/2022658,100 shares $6.13 million -8.6%3.8%2.5 $9.32 12/31/2021720,200 shares $10.23 million -10.1%4.3%3.1 $14.20 12/15/2021800,900 shares $10.36 million -23.0%4.8%3.2 $12.94 11/30/20211,040,000 shares $13.89 million +11.0%6.2%4 $13.36 11/15/2021937,100 shares $12.17 million -25.0%5.6%3.2 $12.99 10/29/20211,250,000 shares $11.38 million +8.7%7.6%2.5 $9.10 10/15/20211,150,000 shares $9.33 million +2.7%7.0%2.1 $8.11 9/30/20211,120,000 shares $8.96 million -8.2%6.8%1.9 $8.00 9/15/20211,220,000 shares $10.57 million +3.4%7.4%2.1 $8.66 8/31/20211,180,000 shares $11.19 million -28.9%7.2%2.1 $9.48 8/13/20211,660,000 shares $19.79 million +55.1%10.3%3.2 $11.92 7/30/20211,070,000 shares $23.94 million +10.0%6.7%3.5 $22.37 7/15/2021972,500 shares $24.25 million +11.5%6.1%4.1 $24.94 6/30/2021872,200 shares $24.92 million +7.6%5.5%3.9 $28.57 6/15/2021810,600 shares $21.76 million +417.6%5.1%3.6 $26.84 5/28/2021156,600 shares $4.95 million -7.8%1.0%0.6 $31.62 5/14/2021169,900 shares $4.61 million -37.3%1.1%0.7 $27.15 4/30/2021271,000 shares $8.35 million +47.0%1.8%0.8 $30.83 4/15/2021184,300 shares $4.91 million +13.5%1.2%0.5 $26.64 3/31/2021162,400 shares $4.98 million +9.1%1.1%0.4 $30.67 3/15/2021148,900 shares $4.78 million +139.4%1.0%0.4 $32.08 2/26/202162,200 shares $1.58 million -0.8%0.4%0.2 $25.43 2/12/202162,700 shares $1.80 million +37.5%0.4%0.2 $28.65 1/29/202145,600 shares $777.48 thousand +8.3%0.3%0.2 $17.05 1/15/202142,100 shares $666.44 thousand -38.4%0.3%0.2 $15.83 12/31/202068,300 shares $808.67 thousand +349.3%0.5%0.5 $11.84 12/15/202015,200 shares $107.46 thousand +149.2%0.1%0.1 $7.07 11/30/20206,100 shares $39.96 thousand -47.0%0.0%0.1 $6.55 11/15/202011,500 shares $74.41 thousand -9.5%0.1%0.1 $6.47 10/30/202012,700 shares $69.47 thousand +84.1%0.1%0.1 $5.47 10/15/20206,900 shares $46.09 thousand -64.1%0.1%0.1 $6.68 EPIX Short Interest - Frequently Asked Questions What is ESSA Pharma's current short interest? Short interest is the volume of ESSA Pharma shares that have been sold short but have not yet been covered or closed out. As of September 15th, investors have sold 1,350,000 shares of EPIX short. Learn More on ESSA Pharma's current short interest. Which institutional investors are shorting ESSA Pharma? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of ESSA Pharma: Group One Trading LLC, and Jane Street Group LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is ESSA Pharma's short interest increasing or decreasing? ESSA Pharma saw a decline in short interest in the month of September. As of September 15th, there was short interest totaling 1,350,000 shares, a decline of 63.1% from the previous total of 3,660,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does ESSA Pharma's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to ESSA Pharma: Pluri Inc. (0.57%), Mersana Therapeutics, Inc. (10.83%), Liminatus Pharma Inc. (4.70%), Sonnet BioTherapeutics Holdings, Inc. (34.15%), Senti Biosciences, Inc. (3.05%), Mural Oncology PLC (4.41%), Eagle Pharmaceuticals, Inc. (0.32%), Alterity Therapeutics Limited - Sponsored ADR (0.41%), Rani Therapeutics Holdings, Inc. (0.18%), Iterum Therapeutics PLC (3.14%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Corporation ($8.81 billion), Canadian Natural Resources Limited ($5.82 billion), Reddit Inc. ($5.19 billion), Coinbase Global, Inc. ($4.52 billion), Robinhood Markets, Inc. ($4.30 billion), Charter Communications, Inc. ($3.75 billion), CoreWeave Inc. ($3.66 billion), Seagate Technology Holdings PLC ($3.57 billion), Live Nation Entertainment, Inc. ($3.33 billion), and Rocket Lab Corporation ($3.26 billion). View all of the most shorted stocks. What does it mean to sell short ESSA Pharma stock? Short selling EPIX is an investing strategy that aims to generate trading profit from ESSA Pharma as its price is falling. EPIX shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ESSA Pharma? A short squeeze for ESSA Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EPIX, which in turn drives the price of the stock up even further. How often is ESSA Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EPIX, twice per month. The most recent reporting period available is September, 15 2025. More Short Interest Resources from MarketBeat Related Companies PLUR Short Interest Data MRSN Short Interest Data LIMN Short Interest Data SONN Short Interest Data SNTI Short Interest Data MURA Short Interest Data EGRX Short Interest Data ATHE Short Interest Data RANI Short Interest Data ITRM Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:EPIX) was last updated on 10/10/2025 by MarketBeat.com Staff From Our Partners"I'm risking my reputation on this"The Fed rate cut truth they don't want you to know The Fed's 25 basis point cut isn't just monetary policy…...Crypto 101 Media | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredElon Warns “America Is Broke”. Trump’s Plan Inside.For the everyday American who's worked hard to build their nest egg, Trump preserved a IRS loophole that allow...American Hartford Gold | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ESSA Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ESSA Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
